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Renal failure caused by mushroom poisoning
Despite the abundance of wild mushrooms growing in a variety of habitats in Taiwan, mushroom poisoning
is rarely reported. Here, we report two cases of mushroom poisoning, possibly due to Amanita smithiana or a
related species. A 54-year-old man and his 52-year-old wife presented with acute anuric renal failure 1 day
after ingesting some white mushrooms they had collected when mountain climbing; they made a full recovery
following hemodialysis and supportive treatment. Although rare, mushroom poisoning should be considered
in the differential diagnoses of acute renal failure. [J Formos Med Assoc 2006;105(3):263–267]
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Despite an abundance of wild mushrooms in
Taiwan, mushroom poisoning is rarely reported.
A previous study indicated a much lower reported
incidence of mushroom poisoning in Taiwan
than in America and Europe, with an incidence of
0.023 exposures per 100,000 people per year.1
Among these previously reported cases, the inci-
dence of major organ failure is even rarer. Most
cases present with self-limited gastrointestinal
symptoms such as nausea, vomiting and abdo-
minal pain.1 Notable in the literature is a report of
an outbreak of nine cases of rhabdomyolysis
caused by Russula subnigricans in 1998.2 Here, we
report mushroom poisoning in a 54-year-old
man and his 52-year-old wife, both of whom
presented with acute renal failure after eating wild
mushrooms presumed to be Amanita smithiana.
They both recovered completely following hemo-
dialysis and supportive treatment. A. smithiana is
a white mushroom with white spores. Before the
year 2000, only 13 cases of poisoning due to in-
gestion of this species and causing acute renal
failure had been reported in North America.3–5 The
prevalence rate of mushroom poisoning in Tai-
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wan is much lower than that reported in the West;1
however, underdiagnosis might contribute to this
difference. Therefore, the gravity of mushroom poi-
soning should not be overlooked.
Case Reports
Case 1
A 54-year-old previously healthy man presented
with a 2-day history of nausea and vomiting, and
a 1-day history of reduced urine output after eat-
ing some wild mushrooms. The ingested mush-
rooms measured approximately 15 cm tall, and
the cap was about 5 cm in diameter. They were
white and also produced a whitish spore print. The
mushrooms were collected while the patient was
mountain climbing at about 2000 m above sea
level in central Taiwan. As the mushrooms were
pulled directly out from the soil, no detailed ob-
servations on the root structure could be made.
However, some wart-like structure was noted over
the caps of the younger mushrooms. The pa-
tient and his wife had both tried a small amount
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sign or hyperactive bowel sounds. Skin turgor
was normal and there was no sign of dehydration.
Sclera were anicteric, the liver and spleen were not
palpable, and there was no costovertebral angle
tenderness. The rest of the physical examination
was unremarkable.
Laboratory data showed elevated blood urea
nitrogen (BUN) of 61.5 mg/dL (normal range,
4.5–24 mg/dL), elevated serum creatinine (Cr)
of 7.2 mg/dL (normal, 0.6–1.3 mg/dL), and a BUN/
Cr ratio of 8.54. Serum sodium was 137 mmol/L
and potassium was 5.0 mmol/L. Liver enzymes
were mildly elevated, with aspartate aminotrans-
ferase (AST) of 30 U/L and alanine aminotrans-
ferase (ALT) of 110 U/L; bilirubin was in the nor-
mal range. Initial white blood cell count was
10,150/μL, with 81.8% neutrophils, which de-
clined soon after admission. There were no signs
of infection and there was no recent use of anti-
biotics. Arterial blood gas showed mild metabolic
acidosis with respiratory compensation, pH 7.38,
PaCO2 32.8 mmHg, and bicarbonate 19.6 mmol/
L. Urinalysis showed a specific gravity of 1.010, a
spot urine protein of 30 mg/dL, and hyaline and
granular casts 0–2/high power field (hpf). Al-
though muscle enzymes were not checked, urinal-
ysis revealed only 1+ occult blood, which was
attributed to Foley catheter insertion causing mi-
croscopic hematuria of 10–20 red blood cells/hpf.
Fractional excretion of sodium (FENa) was 5.6%,
and the renal failure index (urine sodium multi-
plied by plasma Cr, then divided by urine Cr) was
7.65. The influence of pre-renal factors, such as
dehydration due to nausea and vomiting, was con-
sidered to be limited based on the values of serum
BUN/Cr ratio, arterial blood gas, urine specific
gravity, FENa and renal failure index. Renal ultra-
sonogram showed normal-sized bilateral kidneys
(both 10 cm in longitudinal axis), non-distended
urinary bladder and no evidence of hydronephro-
sis. Acute renal failure, presumably mushroom
poisoning-related, was highly suspected.
He and his wife recognized A. smithiana (Figure
1) from a mushroom field guide as the species that
they had eaten, and the physical appearance they
described matched the species as well, except for
of the mushrooms for 2 consecutive days, and no
immediate adverse effect had been noted. There-
fore, they cooked a larger quantity, which they
consumed at supper on the 3rd day. Four hours
later, the patient experienced increased production
of urine. Six hours after the meal, abdominal pain,
nausea and vomiting developed. These symptoms
persisted to the next day.
On initial presentation at a local hospital, he
was treated for presumed acute gastroenteritis
with intravenous fluid and antiemetic agent.
However, he subsequently became anuric on the
same day and visited our emergency department
on the 3rd day. He denied any medication or Chi-
nese herb use, and there was no animal contact or
insect bite during the mountain climbing trip when
the mushrooms were collected.
At this stage, the patient was conscious, alert
and oriented. His height was 165 cm, and he
weighed 61 kg. His body temperature was 36.4°C,
pulse rate was 79 bpm, respiratory rate was 16
breaths per minute, and blood pressure was 143/
81 mmHg. Physical examination revealed only
mild abdominal tenderness without peritoneal
Figure 1.
A photograph
of Amanita
smithiana. It
has a long,
bulbous stipe
(stem) and a
cup (volva) at
the root.
(Reprinted with
permission from
Reference 5.)
265J Formos Med Assoc | 2006 • Vol 105 • No 3
Renal failure caused by mushroom poisoning
a cup-like structure on the root, the volva, which
cannot be seen if the mushrooms are pulled out
instead of dug up. With a presumptive diagnosis
of acute anuric renal failure caused by A. smithiana,
emergency hemodialysis was started and treat-
ment with N-acetylcysteine and silymarin was
also given. Urine output started to increase 9 days
after the poisoning (Figure 2A). Liver enzymes re-
turned to normal soon after admission. Renal
biopsy was suggested but the patient refused. His
systolic blood pressure remained elevated at 150
mmHg and required treatment. Mild hyperkale-
mia and hyperphosphatemia were treated with cal-
cium polystyrene sulfonate, aluminum hydroxide
and calcium carbonate. He was discharged 17
days after mushroom ingestion; 4 weeks after
discharge, his blood pressure normalized, and an-
tihypertensive treatment was discontinued. His
serum Cr level at that time was 1.3 mg/dL.
Case 2
This 52-year-old previously healthy woman was
married to Case 1 and had eaten the same mush-
rooms. She shared the same symptoms and signs
as her husband, except that she did not have ini-
tial polyuria. On presentation to the emergency
department, BUN was 40.4 mg/dL, Cr was 5.2
mg/dL, and AST/ALT was 224/398 U/L, slightly
higher than her husband but which also normal-
ized within days after admission. Urinalysis was
unremarkable. She described a similar clinical
course to her husband’s (Figure 2B), but had nei-
ther hypertension nor electrolyte disturbances. Two
weeks after discharge, all her physical findings and
laboratory data were normal.
Discussion
Mushroom poisoning is usually classified into
the following eight toxin categories:1,6 cyclopep-
tide (amanitin, phalloidin) with hepatocyte dam-
age accounting for most fatalities; orellanine (in
Cortinarius) with late-onset renal failure; mono-
methylhydrazine (gyromitrin) with red blood cells,
hepatocyte and neuronal damage; coprine with
disulfiram-like reactions taken with alcohol; mus-
carine with parasympathomimetic reactions; psy-
choactive ibotenic acid (muscimol) with gamma-
aminobutyric acid (GABA) agonist activity; psilo-
cybin with LSD-like hallucinations; and finally,
miscellaneous gastrointestinal irritants accounting
for most poisoning.1,6 A. smithiana poisoning,
however, cannot be classified into any of these
eight categories and has its own unique present-
ation.
In Taiwan, cyclopeptide-containing species,
the most deadly ones, have only been found at
high altitudes (> 1000 m above sea level), where
few people live.1 For this reason, severe poisoning
is fairly rare in Taiwan. In most cases of mushroom
poisoning, the exact species involved cannot be
identified due to a lack of an available specimen
for examination, or poor preservation of the spec-
imen due to rapid decomposition of the fresh
mushroom at room temperature or in moist
environments. A previous study reported that in
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Figure 2. Daily urine output (U/O) and serum creatinine (Cr) in: (A) Case 1; and
(B) Case 2. Arrows indicate hemodialysis sessions.
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Taiwan, the offending species was identified in
only 28.6% of cases (4 of 14 incidents).1
The unique toxic effects of A. smithiana were
first reported in a mycology journal in 1992.3 Pri-
or to that, acute renal failure was only recognized
as a complication secondary to the fulminate liver
failure caused by the amatoxins found in Amanita
spp.; the most well-known of these species being
Amanita phalloides (the “Death Cap”);7 victims may
require a liver transplantation to survive.7 However,
despite being in the same family, A. smithiana does
not share the same toxins, and its nephrotoxic
agents have been identified as allenic norleucine
and chlorocrotylglycine.4 Another well-known
group of toxins in mushrooms known to cause re-
nal failure are the orellanines found in Cortinarius
spp. With this group, the latent period from the
onset of trivial gastrointestinal symptoms to per-
manent chronic renal failure is longer; from 2
days up to 14 days. Mortality has declined with
modern dialysis, but about 17–41% of patients
require long-term renal replacement therapy or
kidney transplantation.8 Renal biopsies reveal tu-
bular lesions, interstitial nephritis and progressive
fibrosis.8 Acute renal failure caused by A. smithi-
ana ingestion differs from that due to orellanine
intoxication in that it takes place more rapidly, but
may allow full recovery without permanent renal
impairment.
Our review of the literature found that since
1992, three case series including 13 patients with
A. smithiana intoxication have been reported in
North America.3–5 Most patients mistook A. smith-
iana for the edible pine mushroom Tricholoma
magnivelare. In addition, the white “innocent” ap-
pearance of A. smithiana misled its victims to be-
lieve that it was harmless. Gastrointestinal irrit-
ation usually occurred within 4–11 hours and re-
nal failure within 3–5 days.4,5 In some cases, a short
polyuric phase was also noticed before the devel-
opment of anuric renal failure.4 Most patients re-
quired temporary hemodialysis for up to several
weeks, but all eventually returned to their baseline
renal function.4,5 Elderly patients or patients with
diabetes or hypertension appear to have more rap-
id onset, and more severe and longer periods of
renal failure;4 they are also prone to have the ini-
tial polyuric phase as well.4 However, even those
with mild baseline renal function impairment can
make a full recovery as well.4 Despite severe
gastrointestinal symptoms, most patients did not
appear to be dehydrated and oliguria did not
respond to fluid replacement.4 As in our patient,
the physical findings, BUN/Cr ratio and arterial
blood gas in previously reported cases showed no
evidence of dehydration.
No specific treatment for A. smithiana poison-
ing is available. Hemodialysis for acute renal fail-
ure and symptomatic treatment are the most im-
portant therapies.4,5 N-acetylcysteine and silymarin
are the only two reported treatments specific to
amatoxin intoxication, but their benefit remains
debatable.7 Furthermore, use of these treatments
has not been reported in A. smithiana poisoning.
As in most cases of mushroom poisoning in which
no samples of the mushroom were available, our
patients recognized the species they ate from a
mushroom atlas. Due to the similarity in appear-
ance among certain members of the Amanita
family, N-acetylcysteine and silymarin were added
as treatment in case of misidentification, although
their use in these two cases might actually have
been redundant. Activated charcoal may break the
hepatoenteral circulation of amatoxins,7 but no
such circulation has been documented with allenic
norleucine and chlorocrotylglycine, so activated char-
coal may not be applicable in A. smithiana poisoning.
In conclusion, with appropriate supportive care,
total recovery can be achieved, and neither end-
stage renal disease nor hepatic failure have been
reported.
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